1. Home
  2. BLTE vs SIG Comparison

BLTE vs SIG Comparison

Compare BLTE & SIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • SIG
  • Stock Information
  • Founded
  • BLTE 2018
  • SIG 1950
  • Country
  • BLTE United States
  • SIG Bermuda
  • Employees
  • BLTE N/A
  • SIG N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • SIG Consumer Specialties
  • Sector
  • BLTE Health Care
  • SIG Consumer Discretionary
  • Exchange
  • BLTE Nasdaq
  • SIG Nasdaq
  • Market Cap
  • BLTE 1.9B
  • SIG 2.2B
  • IPO Year
  • BLTE 2022
  • SIG N/A
  • Fundamental
  • Price
  • BLTE $61.10
  • SIG $64.40
  • Analyst Decision
  • BLTE Strong Buy
  • SIG Buy
  • Analyst Count
  • BLTE 4
  • SIG 4
  • Target Price
  • BLTE $96.67
  • SIG $69.00
  • AVG Volume (30 Days)
  • BLTE 29.7K
  • SIG 911.5K
  • Earning Date
  • BLTE 05-14-2025
  • SIG 06-03-2025
  • Dividend Yield
  • BLTE N/A
  • SIG 1.99%
  • EPS Growth
  • BLTE N/A
  • SIG N/A
  • EPS
  • BLTE N/A
  • SIG N/A
  • Revenue
  • BLTE N/A
  • SIG $6,703,800,000.00
  • Revenue This Year
  • BLTE N/A
  • SIG $0.64
  • Revenue Next Year
  • BLTE N/A
  • SIG $1.26
  • P/E Ratio
  • BLTE N/A
  • SIG N/A
  • Revenue Growth
  • BLTE N/A
  • SIG N/A
  • 52 Week Low
  • BLTE $40.00
  • SIG $45.55
  • 52 Week High
  • BLTE $86.53
  • SIG $112.06
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 51.45
  • SIG 65.50
  • Support Level
  • BLTE $59.04
  • SIG $59.90
  • Resistance Level
  • BLTE $62.55
  • SIG $65.62
  • Average True Range (ATR)
  • BLTE 2.51
  • SIG 2.25
  • MACD
  • BLTE 0.32
  • SIG 0.59
  • Stochastic Oscillator
  • BLTE 74.06
  • SIG 90.15

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About SIG Signet Jewelers Limited

Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.

Share on Social Networks: